DIGET_BAA Attachment 2_Specific_Program_Plan_Template FINAL.xlsx
XLSX spreadsheet 13 KB Posted
- Attached to
- Detect It with Gene Editing Technologies (DIGET) Federal contract opportunity
- Solicitation number
- HR001120S0016
About this file
This document provides guidance for completing a Specific Program Plan template to support proposals submitted in response to the Defense Advanced Research Projects Agency's Detect It with Gene Editing Technologies broad agency announcement. The Specific Program Plan template requests concise answers about assay and device details, goals, validation and demonstration plans for Phases 1 and 2. Proposals should address detection assays for specific pathogens or biomarkers from various sample types using computational design and internal validation approaches. Phase 1 goals include limits of detection, sensitivity, specificity, multiplex capability, and time to result. Device details incorporate sample preparation, throughput, and detection methods. Integration plans and internal validation processes are also summarized. Proposals must include engagement plans with verification and validation partners for shipping samples and receiving feedback.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| HR001120S0016-Amendment-01.pdf | ||
| Updated DARPA Cost Proposal Spreadsheet - DIGET HR001120S0016.xlsx | XLSX spreadsheet | |
| DIGET_BAA Attachment 3_SOW Template (UPDATE).docx | DOCX document | |
| HR001120S0016.pdf | ||
| DIGET_BAA Attachment 1_Executive Summary Slide for Routing FINAL.PPTX | PPTX presentation | |
| DARPA Cost Proposal Spreadsheet - DIGET HR001120S0016.xlsx | XLSX spreadsheet | |
| DIGET_BAA Attachment 3_SOW Template for Routing FINAL.docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
SPP
Guidance for completing the DIGET Specific Program Plan (SPP):
--Provide key proposal details already described in the full proposal. (Replace existing text below with answers.)
--Provide concise (no more than1-3 sentence answers) to each Program Detail requested. (Some answers may be redundant.)
--Submit in excel format.
| Phase | Topic | Program Detail |
| 1 | TA1 (Detection Assay Design and Development) | Assay summary: targets (specific pathogens, biomarkers, etc.), sample types, enzyme, reporter system |
| 1 | Computational design strategy (e.g., software pipeline used, approach, COTS or custom-built, ML/AI tools, design validation) | |
| 1 | Summary (1-3 sentences) of Internal assay validation plan (e.g., how will assays be tested and evaluated by performer, what is necessary for an assay to pass or be marked for revision) | |
| 1 | Phase 1 Assay goals: Limit of detection, Sensitivity, Specificity, Multiplex, Time (sample to answer) | |
| 1 | Expected performance compared to "gold standard" methods (e.g., x more sensitive than..., x faster than…, x lower LOD than...) | |
| 1 | TA2 (Device Development and Deployment) | MMD summary: sample prep, sample throughput (per run, per day, etc.), detection method, analysis algorithm method, result readout |
| 1 | MMD Phase 1 goals: Limit of detection, Sensitivity, Specificity, Multiplex, Time (sample to answer), Manufacturing | |
| 1 | MMD: Summary (1-3 sentences) of plan to build into current biosurveillance networks | |
| 1 | MMD: Expected Phase 1 performance compared to "gold standard" methods (e.g., x more sensitive than..., x faster than…, x lower LOD than...) | |
| 1 | Point-of-Need summary:sample prep, sample throughput (per run, per day, etc.), detection method, result readout | |
| 1 | Point-of-Need Phase 1 goals: Limit of detection, Sensitivity, Specificity, Multiplex, Time (sample to answer), Manufacturing | |
| 1 | Point-of-Need: Expected Phase 1 performance compared to "gold standard" methods (e.g., x more sensitive than..., x faster than…, x lower LOD than...) | |
| 1 | Capability Demonstration 1 | Demo summary (1-3 sentences): targets, samples, method of testing |
| 2 | Integrated Platform | Integration plan summary (1-3 sentences) |
| 2 | Summary (1-3 sentences) of internal platform validation plan (e.g., how will platforms be tested and evaluated by performer, what is necessary for a platform to pass or be marked for revision) | |
| 2 | MMD summary: sample prep, sample throughput (per run, per day, etc.), detection method, analysis algorithm method, result readout | |
| 2 | MMD Phase 2 goals: Limit of detection, Sensitivity, Specificity, Multiplex, Time (sample to answer), Manufacturing, SWAP, ruggedness, stability | |
| MMD: Expected Phase 2 performance compared to "gold standard" methods (e.g., x more sensitive than..., x faster than…, x lower LOD than...) | ||
| 2 | Point-of-Need summary:sample prep, sample throughput (per run, per day, etc.), detection method, result readout | |
| 2 | Point-of-Need Phase 2 goals: Limit of detection, Sensitivity, Specificity, Multiplex, Time (sample to answer), Manufacturing, SWAP, ruggedness, stability | |
| 2 | Point-of-Need: Expected Phase 2 performance compared to "gold standard" methods (e.g., x more sensitive than..., x faster than…, x lower LOD than...) | |
| 2 | Capability Demonstration 2 | Demo summary (1-3 sentences): targets, samples, method of testing |
| 2 | FDA Submission | Summary (1-3 sentences) of steps and timing for successful FDA submission (e.g., IDE, 510(k), etc) |
| 1+2 | IV&V engagement | Summary of planned engagment with IV&V partners, plans for shipping devices/samples, receiving samples, training materials, etc |
File details come from the government source that posted it. Updated .